Clinical Scorecard: Impact of Surface Hemorrhages on Glymphatic and Dural Lymphatic Function in the Brain
At a Glance
Category
Detail
Condition
Acute subdural hematoma (aSDH) and subarachnoid hemorrhage (SAH)
Key Mechanisms
Glymphatic and meningeal lymphatic systems mediate fluid and solute transport and clearance in the brain; hemorrhages impair these functions
Target Population
Patients with intracranial hemorrhages including aSDH and SAH
Care Setting
Neurosurgical and neuroimaging clinical settings
Key Highlights
Glymphatic influx is markedly impaired after subarachnoid hemorrhage (SAH) in humans.
Acute subdural hematoma (aSDH) may differentially impair dural lymphatic function more than glymphatic function.
Intrathecal gadobutrol-enhanced glymphatic MRI (gMRI) can semi-quantitatively assess glymphatic and dural lymphatic function.
Guideline-Based Recommendations
Diagnosis
Use intrathecal gadobutrol-enhanced glymphatic MRI (gMRI) to visualize and quantify glymphatic and dural lymphatic function.
Perform MRI scans before and 24 hours after intrathecal gadobutrol injection to assess CSF tracer enrichment.
Segment and analyze brain regions using standardized software (e.g., FreeSurfer) for tracer distribution.
Management
Surgical evacuation (craniotomy) is indicated for acute subdural hematoma with impaired consciousness.
Postoperative monitoring for CSF disturbances and neurological recovery is essential.
Consider rehabilitation for cognitive and functional recovery after hemorrhagic brain injury.
Monitoring & Follow-up
Monitor glymphatic and dural lymphatic function post-hemorrhage using serial gMRI when clinically indicated.
Assess CSF tracer clearance to blood as a proxy for meningeal lymphatic drainage capacity.
Evaluate neurological status and cognitive function longitudinally after hemorrhage and surgical intervention.
Risks
Impaired glymphatic and dural lymphatic function may contribute to brain edema and neurological deficits.
External CSF drainage and hydrocephalus treatments can affect glymphatic imaging and function assessments.
Craniotomy and brain injury may cause gliosis and long-term neurological impairment.
Patient & Prescribing Data
Patients with acute subdural hematoma and subarachnoid hemorrhage undergoing glymphatic function assessment
Intrathecal administration of gadobutrol (0.50 mmol) is used as a CSF tracer for glymphatic MRI; no external CSF drainage or hydrocephalus treatment should be present at imaging time.
Clinical Best Practices
Perform glymphatic MRI using standardized protocols and imaging parameters on a 3 Tesla scanner with a 32-channel head coil.
Normalize T1 signal intensity changes against non-enhancing reference tissue (orbital fat) to correct for baseline variations.
Use pharmacokinetic modeling of gadobutrol plasma concentrations to assess CSF clearance and lymphatic drainage.
Include age- and sex-matched control subjects for comparative analysis in research settings.
Interpret glymphatic and dural lymphatic function results in the context of clinical recovery and neurological status.
